首页> 美国卫生研究院文献>Orphanet Journal of Rare Diseases >Early onset torsion dystonia (Oppenheims dystonia)
【2h】

Early onset torsion dystonia (Oppenheims dystonia)

机译:早期扭转性肌张力障碍(奥本海姆肌张力障碍)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Early onset torsion dystonia (EOTD) is a rare movement disorder characterized by involuntary, repetitive, sustained muscle contractions or postures involving one or more sites of the body. A US study estimated the prevalence at approximately 1 in 30,000. The estimated prevalence in the general population of Europe seems to be lower, ranging from 1 in 330,000 to 1 in 200,000, although precise numbers are currently not available. The estimated prevalence in the Ashkenazi Jewish population is approximately five to ten times higher, due to a founder mutation. Symptoms of EOTD typically develop first in an arm or leg in middle to late childhood and progress in approximately 30% of patients to other body regions (generalized dystonia) within about five years. Distribution and severity of symptoms vary widely between affected individuals. The majority of cases from various ethnic groups are caused by an autosomal dominantly inherited deletion of 3 bp (GAG) in the DYT1 gene on chromosome 9q34. This gene encodes a protein named torsinA, which is presumed to act as a chaperone protein associated with the endoplasmic reticulum and the nuclear envelope. It may interact with the dopamine transporter and participate in intracellular trafficking, although its precise function within the cell remains to be determined. Molecular genetic diagnostic and genetic counseling is recommended for individuals with age of onset below 26 years, and may also be considered in those with onset after 26 years having a relative with typical early onset dystonia. Treatment options include botulinum toxin injections for focal symptoms, pharmacological therapy such as anticholinergics (most commonly trihexiphenydil) for generalized dystonia and surgical approaches such as deep brain stimulation of the internal globus pallidus or intrathecal baclofen application in severe cases. All patients have normal cognitive function, and despite a high rate of generalization of dystonia, 75% of those patients are able to maintain ambulation and independence, and therefore a comparatively good quality of life, with modern treatment modalities.
机译:早期发作性扭转肌张力障碍(EOTD)是一种罕见的运动障碍,其特征是涉及身体的一个或多个部位的不自主,重复,持续的肌肉收缩或姿势。一项美国研究估计患病率约为30,000。尽管目前尚无确切的数字,但估计的欧洲总人口患病率较低,范围从33万分之一到20万分之一。由于创始人的突变,估计阿什肯纳兹犹太人口中的患病率大约高五到十倍。 EOTD的症状通常在儿童中期至晚期首先出现在手臂或腿部,在大约五年内,约30%的患者会进展到其他身体部位(全身性肌张力障碍)。在受影响的个体之间,症状的分布和严重程度差异很大。来自各个种族的大多数病例是由染色体9q34上DYT1基因中3 bp(GAG)的常染色体显性遗传继承引起的。该基因编码一种名为TorsinA的蛋白质,该蛋白质被假定为与内质网和核膜结合的伴侣蛋白。它可能与多巴胺转运蛋白相互作用并参与细胞内运输,尽管其在细胞内的确切功能尚待确定。对于年龄在26岁以下的个体,建议进行分子遗传学诊断和遗传咨询,对于具有典型的早期发作性肌张力障碍的亲属的26岁以后的个体,也可以考虑进行分子遗传学诊断和遗传咨询。治疗选择包括针对局部症状的肉毒杆菌毒素注射,针对一般性肌张力障碍的药理疗法(例如抗胆碱能药(最常见的是三苯昔尼))以及在严重病例中采用深部脑刺激内苍白球或鞘内施用巴氯芬的手术方法。所有患者均具有正常的认知功能,尽管肌张力障碍的泛滥率很高,但这些患者中有75%能够通过现代治疗方式保持行走和独立,因此生活质量相对较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号